Investors

OvaScience is a life sciences company focused on the discovery, development and commercialization of new treatments for infertility.

OVAS (Common Stock)
Price & Exchange
$42.10
NASDAQ
Change (%)
 Stock is Down 3.47 (7.61%)
Volume
681,497
03/03/15      4:00 p.m. ET

Minimum 20 minute delay
Refresh quote

Investor Overview

Recent News

More »
DateTitle 
02/26/15OvaScience to Participate in Credit Suisse Global Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 26, 2015-- OvaScienceSM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will participate in the Credit Suisse Global Healthcare One-on-One Conference. The Conference will take place March 3-4, 2015 in London. About OvaScience OvaScience (NASDAQ: OVAS) is a global lif... 
Printer Friendly Version
02/04/15OvaScience to Present at Leerink Global Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 4, 2015-- OvaScienceSM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will present at the Leerink Global Healthcare Conference on Wednesday, February 11, 2015 at 1:25 pm ET at the Waldorf Astoria hotel in New York City. A live audio webcast of the presentation can be access... 
Printer Friendly Version
01/13/15OvaScience Announces Closing of $132 Million Public Offering of Common Stock including Exercise of Underwriters’ Option to Purchase Additional Shares
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 13, 2015-- OvaScienceSM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today the closing of its previously announced public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 345,000 shares of common stock at the public offering price of $50.00 ... 
Printer Friendly Version
01/09/15OvaScience to Present at the J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 9, 2015-- OvaScienceSM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, will present at the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 at 3:30 pm local time at the Westin St. Francis in San Francisco. ... 
Printer Friendly Version

Upcoming Events

More »
There are currently no events scheduled.
Powered by Thomson Reuters
Data Provided by Thomson Reuters
Minimum 20 minutes delayed